CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 81 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,170,000 | +24.9% | 250,804 | -3.0% | 0.07% | -1.4% |
| Q3 2020 | $2,539,000 | -3.3% | 258,533 | -2.1% | 0.07% | -3.9% |
| Q2 2020 | $2,626,000 | +14.1% | 263,958 | +1.4% | 0.08% | -10.6% |
| Q1 2020 | $2,302,000 | +163.4% | 260,362 | +174.9% | 0.08% | +304.8% |
| Q4 2019 | $874,000 | +54.1% | 94,697 | -1.7% | 0.02% | +50.0% |
| Q3 2019 | $567,000 | -52.3% | 96,377 | -2.8% | 0.01% | -50.0% |
| Q2 2019 | $1,189,000 | – | 99,106 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,135,289 | $46,246,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 2,006,211 | $29,592,000 | 5.76% |
| Lyon Street Capital, LLC | 463,064 | $6,830,000 | 2.63% |
| SENZAR ASSET MANAGEMENT, LLC | 335,445 | $4,948,000 | 1.21% |
| INGALLS & SNYDER LLC | 1,209,062 | $17,834,000 | 0.93% |
| Senvest Management, LLC | 314,629 | $4,641,000 | 0.31% |
| KNOTT DAVID M | 45,000 | $664,000 | 0.28% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 262,569 | $3,873,000 | 0.15% |
| PRINCETON CAPITAL MANAGEMENT INC | 14,607 | $215,000 | 0.11% |
| Manchester Capital Management LLC | 19,984 | $295,000 | 0.05% |